World malaria report 2023
<p>India topped countries in the South-East Asia region for the most number of malaria cases and deaths in 2022, according to this report published by the World Health Organization (WHO).</p>
<p>India topped countries in the South-East Asia region for the most number of malaria cases and deaths in 2022, according to this report published by the World Health Organization (WHO).</p>
KAAC Malaria Department in deep hibernation
The world's poorest nations are not prepared for the strain climate change will put on their public health systems, according to studies by the International Institute for Environment and Development (IIED) and partners.
MUMBAI: Parel, Dadar, Byculla and parts of Andheri (E) are emerging as the hotspots for malaria. The BMC has identified 326 chronic sites, including 127 in the island city, 59 in the western suburbs and 13 in the eastern suburbs, where the disease is assuming menacing proportions.
Mumbai Ahead of the advent of monsoon in the city health authorities have warned about the deadly mosquito sting which claims several lives every year. Brihanmumbai Municipal Corporation (BMC) officials have reported a ten per cent rise in confirmed malaria cases this year compared to last year.
A few residents of Jagajeevanramnagar staged a flash protest in front of the Bruhat Bangalore Mahanagara Palike (BBMP) office on Friday demanding compensation for a labourer who died of Malaria. Compensation sought The deceased, Maruthi (36), was rushed to the Victoria Hospital around 11.30 am. He failed to respond to the treatment and passed away at 1 pm.
Pune With no existing vaccine, dengue is a threat to 2.5 billion people and with 50 million cases of dengue fever every year, it is a challenging task to beat this virus.
President Obama asked Congress on Tuesday to spend $63 billion over the next six years on a new, broader global health strategy that would reshape one of the signature foreign policy efforts of his predecessor, George W. Bush.
May be the first new chemical entity developed and marketed by an Indian company. Malvinder singhSix years after the Geneva-based, not-for-profit organisation, Medicines for Malaria Venture (MMV), made Ranbaxy its drug development partner, the latter today announced the start of final-stage clinical trials for a new anti-malaria drug.
New Delhi, May 4 Ranbaxy Laboratories Ltd on Monday announced the commencement of the third phase clinical trials for its new anti-malaria combination drug in India, Bangladesh and Thailand.
Ajai Shukla / Tezpur (assam) May 05, 2009, 0:55 IST